Mohamed F Attia1,2,3, Nicolas Anton4,5, Roman Akasov1,2,6, Manuela Chiper1,2, Elena Markvicheva6, Thierry F Vandamme1,2. 1. University of Strasbourg, Faculty of Pharmacy, 74 route du Rhin, 67401, Illkirch Cedex, France. 2. CNRS UMR 7199, Laboratoire de Conception et Application de Molécules Bioactives, équipe de Pharmacie Biogalénique, University of Strasbourg, route du Rhin No. 74, F-67401, Illkirch Cedex, France. 3. National Research Center, P.O. 12622, Cairo, Egypt. 4. University of Strasbourg, Faculty of Pharmacy, 74 route du Rhin, 67401, Illkirch Cedex, France. nanton@unistra.fr. 5. CNRS UMR 7199, Laboratoire de Conception et Application de Molécules Bioactives, équipe de Pharmacie Biogalénique, University of Strasbourg, route du Rhin No. 74, F-67401, Illkirch Cedex, France. nanton@unistra.fr. 6. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16/10, 117997, Moscow, Russia.
Abstract
PURPOSE: This study aimed to investigate the impact of the size of X-ray iodinated contrast agent in nano-emulsions, on their toxicity and fate in vivo. METHODS: A new compound, triiodobenzoate cholecalciferol, was synthetized, formulated as nano-emulsions, and followed after i.v. administration in mice by X-ray imaging (micro computed tomography). Physicochemical characterization and process optimization allowed identifying a good compromise between X-ray contrasting properties, monodispersity and stability. This also allowed selecting two formulations with different sizes, hydrodynamic diameters of 55 and 100 nm, but exactly the same composition. In vitro experiments were performed on two cell lines, namely hepatocytes (BNL-CL2) and macrophages (RAW264.7). RESULTS: Cell viability studies, cell uptake observations by confocal microscopy, and uptake quantification by fluorimetry, disclosed clear differences between two formulations, as well as between two types of cell lines. After i.v. injection of the two iodinated nano-emulsions in mice, CT scans provided the quantification of the pharmacokinetics and biodistributions. We finally showed that the size in the nano-emulsions has not a real impact on the pharmacokinetics and biodistributions, but has a strong influence on their toxicity, corroborating the in vitro results. CONCLUSIONS: This study shows that the size of the nanocarrier significantly matters, likely due to highly different interactions with cells and tissues. Graphical Abstract A study on the effect of the size of cholecciferol nano-emulsions, on their in vivo becoming, through X-ray imaging modality.
PURPOSE: This study aimed to investigate the impact of the size of X-ray iodinated contrast agent in nano-emulsions, on their toxicity and fate in vivo. METHODS: A new compound, triiodobenzoate cholecalciferol, was synthetized, formulated as nano-emulsions, and followed after i.v. administration in mice by X-ray imaging (micro computed tomography). Physicochemical characterization and process optimization allowed identifying a good compromise between X-ray contrasting properties, monodispersity and stability. This also allowed selecting two formulations with different sizes, hydrodynamic diameters of 55 and 100 nm, but exactly the same composition. In vitro experiments were performed on two cell lines, namely hepatocytes (BNL-CL2) and macrophages (RAW264.7). RESULTS: Cell viability studies, cell uptake observations by confocal microscopy, and uptake quantification by fluorimetry, disclosed clear differences between two formulations, as well as between two types of cell lines. After i.v. injection of the two iodinated nano-emulsions in mice, CT scans provided the quantification of the pharmacokinetics and biodistributions. We finally showed that the size in the nano-emulsions has not a real impact on the pharmacokinetics and biodistributions, but has a strong influence on their toxicity, corroborating the in vitro results. CONCLUSIONS: This study shows that the size of the nanocarrier significantly matters, likely due to highly different interactions with cells and tissues. Graphical Abstract A study on the effect of the size of cholecciferol nano-emulsions, on their in vivo becoming, through X-ray imaging modality.
Authors: Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil Journal: Adv Drug Deliv Rev Date: 2009-04-17 Impact factor: 15.470
Authors: Hanne Boll; Stefanie Nittka; Fabian Doyon; Michael Neumaier; Alexander Marx; Martin Kramer; Christoph Groden; Marc A Brockmann Journal: PLoS One Date: 2011-09-30 Impact factor: 3.240
Authors: James F Hainfeld; Sharif M Ridwan; Yaroslav Stanishevskiy; Nathaniel R Smilowitz; James Davis; Henry M Smilowitz Journal: Sci Rep Date: 2018-09-14 Impact factor: 4.379